Skip to content

Clinical trials

Phase 3 Ovarian Neoplasms trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 3 Country / region: Austria Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20093
20101
20112
20122
20132
20152
20161
20171
20182
20192
20201
20211
20221
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated5
Recruiting4
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
European Organisation for Research and Treatment of Cancer - EORTC3
Hoffmann-La Roche3
AGO Research GmbH2
AstraZeneca2
Merck Sharp & Dohme LLC2
Novartis Pharmaceuticals2
ARCAGY/ GINECO GROUP1
Arcagy Research1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms31
Fallopian Tube Neoplasms11
Carcinoma, Ovarian Epithelial6
Peritoneal Neoplasms3
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Endometrial Neoplasms1
Fibrosarcoma1
Hemangiosarcoma1
Histiocytoma, Malignant Fibrous1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.